Inverness was one of the top ten most searched stocks on TheStreet.com. When it hits their website we should quench the selling, but this was the cost we are paying for their dilution of shares. I am going to follow up with another letter to Motley Fool and tell them to take a second look at BioCurex before they are too late to the party.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.